Bluefin Capital Management’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-19,249
Closed -$34K 593
2021
Q4
$34K Buy
+19,249
New +$34K ﹤0.01% 521